CCL2 and COVID-19: Identification of cluster 12 comprising monocyte-related analytes (fractalkine, MCP-1, and TRAIL) in plasma further supports a targeted impact of SARS-CoV-2 infection on monocyte recruitment to lung respiratory mucosa contributing to exaggerated pathogenicity of COVID-19.